Ascendis Pharma A/S - ADR

NASDAQ:ASND   3:59:51 PM EDT
163.47
-0.53 (-0.32%)
Earnings Announcements

Ascendis Pharma A/S Reports Second Quarter 2021 Financial Results

Published: 08/25/2021 20:36 GMT
Ascendis Pharma A/S - ADR (ASND) - Reports Second Quarter 2021 Financial Results.
Q2 Loss per Share EUR 2.50.
Q2 Revenue EUR 1.0 Million Versus EUR 1.4 Million.
Revenue is expected to be $2.74 Million
Adjusted EPS is expected to be -$2.70

Next Quarter Revenue Guidance is expected to be $8.24 Million
Next Quarter EPS Guidance is expected to be -$2.80

More details on our Analysts Page.